Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Piette

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Pediatric Blood & Cancer|November 30, 2024
Quality of Life Priorities of Childhood Acute Lymphoblastic Leukemia Survivors Enrolled in EORTC Studies, and a Comparison of InstrumentsJammbe Musoro, Charlotte Sleurs, Ali Rowsell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemiaKjeld Schmiegelow, Mette Frandsen Levinsen, Andishe Attarbaschi, et al.
The Lancet. Oncology|June 15, 2016
Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensusKjeld Schmiegelow, Andishe Attarbaschi, Shlomit Barzilai, et al.
British Journal of Haematology|December 15, 2019
Long-term outcome evaluation of medium/high risk acute lymphoblastic leukaemia children treated with or without cranial radiotherapy in the EORTC 58832 randomized studyCaroline Piette, Stefan Suciu, Yves Bertrand, et al.
Hemasphere|November 14, 2024
Results of the prospective EORTC Children Leukemia Group study 58081 in precursor B- and T-cell acute lymphoblastic leukemiaCarine Domenech, Michal Kicinski, Barbara De Moerloose, et al.
Human Reproduction (Oxford, England)|November 17, 2021
Fertility status among long-term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: results of the 58 Late Adverse Effects studyGiovanna Rossi, Michal Kicinski, Stefan Suciu, et al.
European Journal of Cancer Care|October 26, 2022
Socio-economic outcomes among long-term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: Results of the 58LAE studyMelissa Barbati, Michal Kicinski, Stefan Suciu, et al.
British Journal of Haematology|May 25, 2019
Results of successive EORTC-CLG 58 881 and 58 951 trials in paediatric T-cell acute lymphoblastic leukaemia (ALL)Mattias Hofmans, Stefan Suciu, Alina Ferster, et al.
Discover Oncology|January 29, 2024
Long-term neurotoxicity among childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC Children Leukemia Group studiesMaëlle de Ville de Goyet, Michal Kicinski, Stefan Suciu, et al.
The Lancet. Haematology|June 25, 2021
Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemiaLiv Andrés-Jensen, Andishe Attarbaschi, Edit Bardi, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Pediatric Blood & Cancer|November 30, 2024
Quality of Life Priorities of Childhood Acute Lymphoblastic Leukemia Survivors Enrolled in EORTC Studies, and a Comparison of InstrumentsJammbe Musoro, Charlotte Sleurs, Ali Rowsell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemiaKjeld Schmiegelow, Mette Frandsen Levinsen, Andishe Attarbaschi, et al.
The Lancet. Oncology|June 15, 2016
Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensusKjeld Schmiegelow, Andishe Attarbaschi, Shlomit Barzilai, et al.
British Journal of Haematology|December 15, 2019
Long-term outcome evaluation of medium/high risk acute lymphoblastic leukaemia children treated with or without cranial radiotherapy in the EORTC 58832 randomized studyCaroline Piette, Stefan Suciu, Yves Bertrand, et al.
Hemasphere|November 14, 2024
Results of the prospective EORTC Children Leukemia Group study 58081 in precursor B- and T-cell acute lymphoblastic leukemiaCarine Domenech, Michal Kicinski, Barbara De Moerloose, et al.
Human Reproduction (Oxford, England)|November 17, 2021
Fertility status among long-term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: results of the 58 Late Adverse Effects studyGiovanna Rossi, Michal Kicinski, Stefan Suciu, et al.
European Journal of Cancer Care|October 26, 2022
Socio-economic outcomes among long-term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: Results of the 58LAE studyMelissa Barbati, Michal Kicinski, Stefan Suciu, et al.
British Journal of Haematology|May 25, 2019
Results of successive EORTC-CLG 58 881 and 58 951 trials in paediatric T-cell acute lymphoblastic leukaemia (ALL)Mattias Hofmans, Stefan Suciu, Alina Ferster, et al.
Discover Oncology|January 29, 2024
Long-term neurotoxicity among childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC Children Leukemia Group studiesMaëlle de Ville de Goyet, Michal Kicinski, Stefan Suciu, et al.
The Lancet. Haematology|June 25, 2021
Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemiaLiv Andrés-Jensen, Andishe Attarbaschi, Edit Bardi, et al.
Pageof 4